{"schema":"sb.node.v1","id":"sb:e/5f57cc4d91657e957ee99f92","kind":"entity","label":{"text":"pdac","locale":"en"},"identity":{"anchor":"label:en:pdac","strength":"label"},"asOf":{"knowledgeCutoff":"2026-10-06T19:01:48.073148+00:00","snapshot":"deploy 5dfee874e7fefec07fed541777335b2d587f80c6"},"lens":{"kind":"public"},"build":{"plane":"projected","builtFrom":["entity_graph.slim.json","entity_receipts (deploy asset)","event_graph.json","truth_records (deploy asset)","corroborated_record.json"],"rule":"node-projection.entity@v1"},"standing":{"evidence":{"supporting":37,"separatePublishers":15,"basis":"documents that mention the subject and the outlets that carried them; a mention is evidence the referent is in use, not evidence about any claim"},"admission":{"state":"canonical","reason":"entity graph provenance 'curated'; the node carries no promotion receipt in v1","policy":"EQ-PROMOTION (receipt not carried)"},"disposition":{"state":"served","reason":"public record"},"validity":{"from":"2026-04-08","to":"2026-10-02","basis":"first and last day we saw it mentioned; not the subject's own lifetime"},"measurement":{"state":"partial","blind":["assertion coverage 0.081: about 92% of mentions carry no typed assertion"]}},"dimensions":{"domains":["pubmed_targeted","oncology","precision_medicine"],"activeDays":31,"assertions":{}},"up":[],"upNote":"An entity is a root: it is contained by nothing. Pan out by following R.","children":{"count":12,"byKind":{"observation":12},"items":[{"id":"sb:o/ffed75995fc2024cc7fced21","kind":"observation","label":"Inside Precision Medicine · 2026-10-01 · Oncolytic Virus May Boost First-in-Line Chemotherapy for Metastatic PDAC","url":"https://www.insideprecisionmedicine.com/topics/oncology/oncolytic-virus-may-boost-first-in-line-chemotherapy-for-metastatic-pdac/"},{"id":"sb:o/d2e7022309f8e2b8a74daf48","kind":"observation","label":"KRAS Mutation Research (Google News) via Google News · 2026-09-17 · Phase 1 Data Support DAWN-303’s Evaluation of INCB161734 in Frontline KRAS G12D–Mutated PDAC - OncLive","url":""},{"id":"sb:o/348e2eabd7eabadcf0ae1744","kind":"observation","label":"Cancer Res · 2026-10-02 · Targeting Distinct Cell Cycle Nodes Overcomes RAS Inhibitor Resistance.","url":"https://doi.org/10.1158/0008-5472.CAN-26-1315"},{"id":"sb:o/6a931cb2c80562aff8124c0c","kind":"observation","label":"GEN - Genetic Engineering & Biotechnology News · 2026-09-30 · Merck, SciBrunch Launch Up-to-$2.13B Collaboration to Develop Preclinical KRAS-Inhibiting Molecular Glue","url":"https://www.genengnews.com/topics/cancer/merck-scibrunch-launch-up-to-2-13b-collaboration-to-develop-preclinical-kras-inhibiting-molecular-glue/"},{"id":"sb:o/cdaf58b3ecbddad70977fce9","kind":"observation","label":"Expert Opin Biol Ther · 2026-09-28 · Harnessing novel agents to target KRAS-driven pathways in pancreatic cancer.","url":"https://doi.org/10.1080/14712598.2026.2738708"},{"id":"sb:o/519d9a8a2891f95f40ad3c3a","kind":"observation","label":"Frontiers Precision Oncology · 2026-09-25 · Individualized treatment of HER2-positive breast cancer patients with lung metastasis using a circulating tumor cell drug sensitivity test: a case report","url":"https://www.frontiersin.org/articles/10.3389/fonc.2026.1888730"},{"id":"sb:o/0544879d180edb13adb21590","kind":"observation","label":"bioRxiv Cancer Biology · 2026-09-25 · Context-specific genetic interaction mapping reveals combinatorial KRAS/FGFR dependence in pancreatic cancer","url":"https://www.biorxiv.org/content/10.64898/2026.09.24.754062v1?rss=1"},{"id":"sb:o/2d9c8b2feffa13af5beb9cb9","kind":"observation","label":"bioRxiv Cancer Biology · 2026-09-25 · ALDH1B1 promotes mitochondrial γ-butyrobetaine biosynthesisand fatty acid oxidation in colorectal cancer","url":"https://www.biorxiv.org/content/10.64898/2026.09.24.753323v1?rss=1"},{"id":"sb:o/d36fa9b95d05d1d22b0da0cc","kind":"observation","label":"Inside Precision Medicine · 2026-09-24 · New Immunotherapy Strategy Extends KRAS Inhibitor Response in Pancreatic Cancer","url":"https://www.insideprecisionmedicine.com/topics/oncology/new-immunotherapy-strategy-extends-kras-inhibitor-response-in-pancreatic-cancer/"},{"id":"sb:o/e5a396470aa183f1936cba20","kind":"observation","label":"GEN - Genetic Engineering & Biotechnology News · 2026-09-24 · Genialis and Inventia Life Science Collaborate to Link Patient Biology with 3D Pancreatic Cancer Models","url":"https://www.genengnews.com/topics/cancer/genialis-and-inventia-life-science-collaborate-to-link-patient-biology-with-3d-pancreatic-cancer-models/"}],"cursor":"c1.eyJpZCI6InNiOmUvNWY1N2NjNGQ5MTY1N2U5NTdlZTk5ZjkyIiwibCI6ImNoaWxkcmVuIiwibyI6MTAsImsiOm51bGwsImEiOiIyMDI2LTEwLTA2VDE5OjAxOjQ4LjA3MzE0OCswMDowMCJ9","order":"newest first; we keep the 12 newest receipts for this entity. Its other observations are counted in standing.evidence.supporting but are not addressable in v1"},"relations":{"count":4,"byKind":{"co-mentioned":4},"items":[{"kind":"relation","label":"co-mentioned with kras (23 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/804a650e8d5ad2ceb6fb5fd8"},{"kind":"relation","label":"co-mentioned with pancreatic cancer (20 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/c5e1c60f3bc6a641dffac603"},{"kind":"relation","label":"co-mentioned with immunotherapy (9 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/5a5e37185e2766318dbd4e3d"},{"kind":"relation","label":"co-mentioned with colorectal cancer (8 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/4743f48a7b64dddbef0cb472"}],"cursor":null,"order":"situations first, then claims (the subject's own maintained record, then site-wide corroborated clusters; each label ends with its standing), then co-mentions by shared documents, descending. Co-mentions are the ten strongest the entity graph keeps per entity"},"edge":{"state":"continues"},"links":{"rest":"/api/v1/node/e/5f57cc4d91657e957ee99f92","mcp":"traverse {\"id\":\"sb:e/5f57cc4d91657e957ee99f92\"}","page":"/entity/pdac/"},"limits":{"levelsPerCall":1,"pageSize":10,"maxPageSize":50,"membersMax":50,"statement":"One level per call: depth is 1 and only 1, and there is no whole-graph dump. pageSize 1-50 (default 10); a page limit is a cursor, never an edge. Members are listed up to 50. At most 60 traverse calls a minute per caller (runaway-loop protection, not a meter). One knowledge cutoff is served: the deploy's."},"actions":[{"verb":"unfold","lit":true,"effect":"read","layer":"cantina","call":"traverse {\"id\":\"sb:e/5f57cc4d91657e957ee99f92\",\"level\":\"children\"}"},{"verb":"fold","lit":true,"effect":"read","layer":"cantina","call":"traverse {\"id\":\"sb:e/5f57cc4d91657e957ee99f92\"}"},{"verb":"panOut","lit":false,"effect":"read","layer":"cantina","reason":"An entity is a root: it is contained by nothing. Pan out by following R."},{"verb":"follow","lit":true,"effect":"read","layer":"cantina","call":"traverse {\"id\":\"sb:e/5f57cc4d91657e957ee99f92\",\"level\":\"relations\"}"},{"verb":"receipts","lit":false,"effect":"read","layer":"cantina","reason":"receipts are the observations below this node; unfold to reach them"},{"verb":"edge","lit":true,"effect":"read","layer":"cantina","call":"traverse {\"id\":\"sb:e/5f57cc4d91657e957ee99f92\"}"},{"verb":"asOf","lit":false,"effect":"read","layer":"cantina","reason":"v1 serves one knowledge cutoff, this deploy's; walking an earlier cutoff needs retained history (EQ-REPLAY), which v1 does not keep"},{"verb":"switchObserver","lit":false,"effect":"read","layer":"cantina","reason":"the public record is the same for every observer; traversal through a Watch's lens is not served in v1"},{"verb":"readOriginal","lit":false,"effect":"read","layer":"cantina","reason":"no translation is applied on this node; every label is the source's own text"},{"verb":"save","lit":false,"effect":"watch-declaration","layer":"workshop","reason":"saving applies to a configured Watch; configure one around this node first (free), then save it"},{"verb":"deliver","lit":false,"effect":"watch-declaration","layer":"workshop","reason":"delivery applies to a saved Watch"},{"verb":"format","lit":false,"effect":"watch-declaration","layer":"workshop","reason":"output format applies to a saved Watch"},{"verb":"deltaR","lit":false,"effect":"read","layer":"workshop","reason":"Delta R needs a saved Watch with a previous reading"},{"verb":"read","lit":false,"effect":"read","layer":"docking-bay","reason":"one-time Reads are parked until the Commander decides their shape (#938)"}]}